Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial

Efficacy and safety of tocilizumab (TCZ), an interleukin-6 receptor inhibitor, were demonstrated in juvenile idiopathic arthritis (JIA) with polyarticular course (pJIA) in the CHERISH trial. This observational, III phase study evaluated long-term treatment of TCZ in pJIA patients was conducted by me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Rheumatol
Autores principales: Opoka-Winiarska, Violetta, Żuber, Zbigniew, Alexeeva, Ekaterina, Chasnyk, Vyacheslav, Nikishina, Irina, Dębowska, Grażyna, Smolewska, Elżbieta
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer London 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006189/
https://ncbi.nlm.nih.gov/pubmed/29654485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-018-4071-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares